chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Administered vaccines which refroze; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccines which refroze) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccines which refroze). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccines which refroze) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided. No Treatment medications were provided. Healthcare provider, a clinic manager reports that they received 20 vials of the Moderna Covid-19 vaccine on 25May2021 from their local health department in frozen state. They used 10 vials in vaccination clinic. They were going to use the remaining 10 vials on 22Jun2021, in their vaccination clinic but they were informed by the health department that they do not transport the vaccines in frozen state, they always do in liquid state at 32 F.  The health department requested the clinic manager to call Moderna to know if these 10 vials were still viable.  The vials were still in the freezer  at -4F.
Swelling, redness, hot to the touch, itchiness, 3" x 4"
RD-sore, stiffness, redness and warm to touch after flu shot. Warm compresses and TYLENOL done by client.
adult patient inadvertently received a pediatric dose of Engerix-B; adult patient inadvertently received a pediatric dose of Engerix-B; This case was reported by a nurse via call center representative and described the occurrence of accidental underdose in a 52-year-old male patient who received HBV (Engerix B pediatric) (batch number F22EZ, expiry date 3rd June 2023) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 7th April 2022, the patient received Engerix B pediatric 10 µg. On an unknown date, the patient started Engerix B Pre-Filled Syringe Device. On 7th April 2022, unknown after receiving Engerix B pediatric and an unknown time after starting Engerix B Pre-Filled Syringe Device, the patient experienced accidental underdose and adult use of a child product. On an unknown date, the outcome of the accidental underdose and adult use of a child product were unknown.   It was unknown if the reporter considered the accidental underdose and adult use of a child product to be related to Engerix B Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 07-Apr-2022 Reporter's Comments: The reporter stated that an adult patient inadvertently received a pediatric dose of Engerix-B. The reporter consented to follow up. Additional Supportive Information: The patient was administered pediatric dose of Engerix B, which led to accidental underdose and adult use of a child product.
Patient reported experiencing numbness, tingling, and weakness on all limbs. This started the day after she got the vaccine and has continued off and on until present day. She contacted her provider who does not think it is related to the vaccine but she believes it is.
3 days after vaccine I developed hives at the site of injection only  and prior to this had surrounding erythema with mild swelling, warmth, and significant tenderness.
Numbness in extremities, itching, caused tremors, stiffness in joints, dizziness, insomnia. No treatment given. Patient believes gelatin and octylphenol may have triggers tremors. Found in inactive ingredients.
Red patch on arm for about 10 days, he in size to 4"x6". Tingling on tongue. Pain on back of head for several days,  still continuing. Numbness in left jaw, Loss of muscle use on left side of face. Went to ER where they indicated Bell's palsy.
Patient developed sudden dizziness upon leaving the recovery area, and was accompanied by staff to a laying position on a cot.  HR 85, 10:05; BP 154/97, no additional symptoms. 10:10; HR 85, BP 154/97 dizziness improving, no new sx 10:15; HR 84, BP 151/95 dizziness improving, no new sx 10:20; HR 80, BP 134/89 dizziness improved
blood sugar is little high; feels weak; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (blood sugar is little high), ASTHENIA (feels weak) and VOMITING (vomiting) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced BLOOD GLUCOSE INCREASED (blood sugar is little high), ASTHENIA (feels weak) and VOMITING (vomiting). At the time of the report, BLOOD GLUCOSE INCREASED (blood sugar is little high), ASTHENIA (feels weak) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose increased: high (High) blood sugar is little high.         Action taken with mRNA-1273 in response to the drug was not applicable. No concomitant medication information was provided. No treatment medication information was provided.
approx 3 days after pfizer covid vaccine dose 2, i developed diffuse very itchy maculopapular rash. L leg, R arm, trunk. rash is red, raised, itchy, about 1 cm. about 15 separate lesions.
Within a few weeks of the second Moderna Covid vaccination, I began to have heart palpitations, irregular heart rate, chest pressure/pain, shortness of breath, exacerbation of my previously mild asthma symptoms, and fatigue.  These became progressively worse over time, resulting in a visit to the emergency room in May 2021, as the palpitations, irregular heart rate, and chest pressure made me unable to sleep, and worried that I was having a heart attack or other cardiac event.
I have welts on either side of my head, that are itchy, but I am not scratching them
Pain and tenderness in associated arm and 101*F fever 30 hours after vaccine was administered.
Reports sxs of tingling on face, hives R side of face, sore throat, chest palpitations, chest pain, SOB, swollen forehead and nose, and back pain.
Approx 20 mins after injection, the site began to sting, burn, and turn red. The burning and redness continued to occur. The next day my arm was very stiff from the shoulder to fingers. It continued this way for approx 48 hours. Benadryl was taken. When seen by my physican he prescribed Medrol Dosepak.
This spontaneous report as received from a healthcare worker refers to a two unspecified patients of unknown age and gender. No information on patients medical history, concurrent conditions or concomitant medications was provided. On 14-JUL-2015, one patient was inadvertently vaccinated with a dose of (Oka/Merck) VARIVAX injection, lot # K011801, expiration date 21-AUG-2016 (strength, route of administration and dose were not reported) that had been improperly stored. On 17-JUL-2015, one additional patient was inadvertently administered with a dose of (Oka/Merck) VARIVAX injection, lot # K011801, expiration date 21-AUG-2016 (strength, route of administration and dose were not reported) that had been improperly stored. No adverse effects were reported. Additional information has been requested.
sever and rapid heart beat.  treated at home, (not a smart move)  lasted approx 3 hrs. at severe rate, another 4 hrs at lower rate that was still too high. treated by holding ice pack on face.  next time I will go to er.
Vaccine was given subcutaneously and not IM.  Pain at injection site - redness at injection site.
About one minute after the IM injection, my L arm began tingling.  Then, my R arm began tingling also a little.  I felt strange sensations in my upper and lower chest.  These continued for about 5 days.  I developed a mild headache.  It lasted about 7 days.  It felt like it was just above my skull and all over my head.  I felt strange, a mildly painful sensations in my left lower jaw and in the back of my left eye.    I feel substernal tighness in my chest.  This continues until today, Feb. 8 (11 days later).  I went to the Emergency Room for this tighness in my chest.  (I had COVID-19 infection in Dec. 2020.)
shortness of breath. left leg pain, HA, Dizzy, nauseated, HA, sweaty, dizzy
Eye muscle weakness, double vision muscle weakness in face and neck. Diagnosis: Myasthenia Gravis
Day after vaccinations on 4-6-10 pt. presented with (R) arm redness and swelling. Mother advised to give Ibuprofen and ice area. Two days later on 4-8-10 pt seen in office - (R) arm still swollen and warm to touch. Pt c/o no pain only itchiness. Advised to take BENADRYL.
Lower back pain/tightness; Lower back pain/tightness; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 30 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Jun2021 15:00 (Lot number EW0182) at the age of 30 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: CLARITIN D 12 HOUR; XULANE. Vaccination history included Bnt162b2 (product COVID 19, brand Pfizer-BioNTech, lot number ew0172, lot unknown False, administration date=12May2021, administration time 03:15 PM, dose number 1, Vaccine location Left arm), administration date 12May2021, when the patient was 30 years old, for COVID-19 immunisation. The following information was reported: BACK PAIN (non-serious), MUSCLE TIGHTNESS (non-serious) all with onset 05Jun2021 07:30, outcome not recovered and all described as Lower back pain/tightness. The event lower back pain/tightness and lower back pain/tightness was evaluated at the physician office visit. Therapeutic measures were taken as a result of back pain, muscle tightness.  Additional information: Patient did not administered any vaccine in four weeks. 36hours after the second injection. Patient did not receive any treatment like acupuncture, Cupping, Physical Therapy prior covid vaccination.  Follow-up (27Jul2021): Follow-up attempts are completed. No further information is expected.
Skin rash on hands and ankles. Itches and burning sensation.  No treatment by patient to date.
Diarrhoea; Vomiting; Nausea; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported for a female patient (Wife). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 01Sep2021 at dose 1, single for covid-19 immunisation. Medical history and concomitant medications were not reported. On an unspecified date in Sep2021 the patient experienced diarrhoea, vomiting, nausea. Additional Context: Concern: Reporter stated, Me and my wife had the first shot of the Pfizer vaccine on September the first and she just started having diarrhoea and vomiting. So, nausea, could that be coming from the vaccine. Concern Paraphrased: Reporter stated, Right, we had it September the first. We both went for our first shot September the first. Reporter stated, no, right now I got to check on her. She been living around awful. So I am trying to find out if it be coming from the Pfizer. Outcome of the events was unknown.  The lot number for the vaccine [BNT162B2] was not provided and will be requested during follow up.  Follow-up attempts are completed. No further information is expected.
SHORTNESS OF BREATH with hypoxia, D satting into the 80s when she sleeps at night, now at about the 11th day of illness with COVID-19.Diagnosed with covid on 10/10, presented to outside hospital on 10/12, after having been sick for about 9 days.
This case was reported by a consumer, via manufacturer and described the occurrence of pain in arm post vaccination in a female subject of unspecified age who was vaccinated with Influenza vaccine, manufacturer unspecified). A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of Influenza vaccine (unknown). At an unspecified time after vaccination with Influenza vaccine, the subject experienced pain in arm post vaccination. The subject reported "when she receives her yearly flu vaccine (manufacturer unknown) her arm hurts." No other information was provided.
got so so sick; Bed for 3 days with high fever; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness and fever. On an unknown date, the outcome of the sickness was unknown and the outcome of the fever was recovered/resolved.   The reporter considered the sickness to be related to Shingles vaccine. It was unknown if the reporter considered the fever to be related to Shingles vaccine.  Additional details were provided as follows: The patient reported case for him/herself. The age at vaccination was not reported. The patient got so sick from Shingles vaccine. After receiving Shinlges vaccine, the patient was in bed for 3 days with high fever. The patient stated that, he/she would not get the other one and  would take his/her chances.
About four hours after receiving dose 2 of pfizer vaccine, I began sneezing, had a tickle in my throat and terribly itchy eyes. Then my eyes and throat swelled up so much that I couldn't open my right eye.
Received vaccine in left thigh. Developed fevers and leg swelling day after. Leg stayed swollen for 2-3 days after vaccine given.
Pt complained of redness at the injection site starting 2 weeks and 2 days after the administration along with itching.  Pt denied pain/opening in skin/any other s/s.
About one week after receiving the first dose of the Pfizer Covid-19 vaccine, I developed a rash on two fingers of my left hand that itches. I used OTC hydrocortisone cream on it, which relieved the symptoms temporarily. Rash is still present today. I received the second dose of the vaccine yesterday, 1/9/2021, in my right arm, and today I noticed the rash is spreading to my right hand. I have not had any previous adverse reactions to any other vaccine. I went to urgent care today and the nurse practitioner recommended me to take Benadryl 25 mg at night to relieve symptoms.
After 3rd Gardasil vaccination my daughter came down with body aches, joint pains, generally not feeling well, nausea, vomiting, chills, chest pain, congestion, slight fever, shortness of breath, extreme fatigue - 4 days later (3/27/2015) cough and greater congestion - 6 days later (3/29/2015) redness in both eyes with no itching or oozing, just red - 7 days (3/30/2015) greater cough and laryngitis. She has been more fatigued since the first injection.
Pt describes an outbreak of genital herpes ( pt has prior history of genital herpes) 2-3 days after receiving each Shingrix vaccine, April 1, 2019 and June 11, 2019. Patient was not seen for the outbreak, she took valacyclovir as prescribed for herpes outbreak.
pt recvd vax about 1300; mom states @ 1400 pt had edema to rt eye & raised reddened rash to back;
3.5 x 2 cm (R) thigh erythema with firm palpable area not fluctuant.
Starting about 48 hours post vaccine, I noticed increased in arthritis pain. The pain was at top of spine, neck and back of head. On a scale of 1-10 the pain is about 4.  The pain slowly went away. It took about 4 days for the pain to go away.  I regularly see my chiropractor who helps with my pain management.
shingles; debilitating stroke; This spontaneous report was received from a lawyer regarding a case in litigation, referring to a female patient of unknown age. The patient's medical history, concurrent condition and concomitant medication were not reported.   On 06-AUG-2010 the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route, strength, batch/lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).         In approximately October 2010, reported as approximately two months after receiving zoster vaccine live (ZOSTAVAX), the patient suffered a debilitating stroke and eventually experienced outbreaks of shingles, all caused by the zoster vaccine live (ZOSTAVAX). As a direct and proximate result of Merck's defective zoster vaccine live (ZOSTAVAX) vaccine, the patient's symptoms have resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX) and caused by the zoster vaccine live (ZOSTAVAX) vaccine. The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and disfiguring personal injuries. Further, as a tragic consequence of Merck's wrongful conduct. the patient suffered serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. Aa direct and proximate result of Defendants' conduct, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of debilitating stroke and shingles was not resolved. The reporter considered the events to be related to Zoster Vaccine Live(ZOSTAVAX).  The reporter considered the debilitating stroke and shingles to be serious due to disability.  Upon internal review, the event stroke was determined to be medically significant.  Additional information has been requested.
Pregnant patient; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient) in a 42-year-old female patient (gravida 3, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included Cramp (Light cramping during this pregnancy) and Spotting vaginal (Spotting during this pregnancy). Concurrent medical conditions included Drug allergy (The patient is sensitive to codeine.). Concomitant products included FISH OIL and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 28-Jan-2021 and the estimated date of delivery was 04-Nov-2021. On 24-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  third week of the pregnancy.  On 24-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, Pregnancy test: positive (Positive) Positive. On an unknown date, Blood test: normal (normal) Everything was normal. On an unknown date, Ultrasound scan: normal (normal) Everything looked normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.  The estimated date of conception was on 10-Feb-2021.  Pregnancy history:  Pregnancy date: 02-Aug-2019, Outcome: Live birth. Pregnancy date: 30-Sep-2020, Outcome: Miscarriage.
Vaccine administered after the expiration date of 04/28/2021. Patient reports no adverse events.
GBS dx 18DEC98?;sx began w/pain in legs progressed to weakness of legs, unable to walk then, loss of tx of arms;under care of MD;
Within a few seconds, I noticed a metallic taste in my mouth.  Within 1-2 minutes, the left side of my jaw felt like after you get novocaine at the dentist.  It was not as much as when you have a filling drilled, but it was a definite numbness from the base of my left ear to the front side of my chin.
Dizziness, nausea, headache, feeling on lip swelling and "dripping" feeling to back of throat
Patient received 3rd dose Pfizer but stated they lost their vaccination record card. Patient and caregiver confirmed patient did receive Pfizer for first two doses and that it had been atleast 6 months since the 2nd dose. Consulted database and there was no record of first two doses. Patient was administered Pfizer vaccine, and the pharmacy followed up with another agency to confirm dates and lot numbers. At that time, it was discovered the patient actually received Moderna for the first two doses.
In addition to the usual side effects (chills, aches, fatigue) I found my arms and legs were shaking significantly after the booster shot (shaking started ~18 hours after the shot and ended 48 hours after). At one point, my legs were shaking so much that my wife had to help me sit down on the floor in the hallway of our apartment so that I didn't fall. I had to sit for ~1 minute before being able to support my own weight again.
began pulling out hair went on prozac;mood swings,h/a,sweating,hot flashes,neck&back stiffness,abd pain;diarrhea-constipation,weakness,flushed,memory loss,trouble w/eyes,breathing hard,purpura,ringing in ear,muscles aches
This spontaneous report as received from a pharmacist refers to a 73 year old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 14-MAY-2016, the patient was vaccinated with ZOSTAVAX (dose, route of administration, lot # and expiration date were not reported) for prophylaxis. Other suspect therapies included PREVNAR 13. On an unknown date, the patient experienced local injection site reaction. The patient told pharmacist that she was not sure if reaction was due to ZOSTAVAX or PREVNAR 13. The outcome of injection site reaction was reported as recovered/resolved. Additional information has been requested.
This spontaneous report as received from a pharmacist via a company representative refers to a female patient of unknown age (the reporter's wife). Information regarding the patient's pertinent medical history, drug reactions or allergies was unknown. On an unknown date, approximately in 2015 (reported as 2 and a half years ago), the patient was vaccinated with ZOSTAVAX (dose, route of administration, lot# and expiration date were not reported) for prophylaxis. On an unknown date, approximately in 2015 (reported as 15 days after vaccination), the patient developed herpes zoster in the head region. On an unknown date, the patient started to experience post herpetic neuralgia. The patient sought medical attention by visiting multiple pain specialists on unknown dates, however it was unknown if she received any treatment for the events. It was unknown if the patient had shingles rash at the reporting time. She had not recovered from post herpetic neuralgia till the time of the report. Causality assessment was not provided.